News
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, April 10, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) ...
US and China-based ProfoundBio will use part of the proceeds for a pivotal trial in ovarian cancer of rinatabart ... Surveyor Capital, Medicxi, Logos Capital, Octagon Capital, Piper Heartland ...
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...
6d
News-Medical.Net on MSNChemoID test leads to better outcomes in platinum-resistant ovarian cancerResults from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...
Her doctor was concerned, but mentioned that the bleeding could be due to an internal hemorrhoid, which is common after childbirth. But results from an at-home stool test indicated Qadir needed a ...
To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
This particular genetic mutation is most commonly associated with an increased risk for breast cancer and ovarian cancer, says Parikh, who is also Qadir’s oncologist. While we can screen for ...
6d
News-Medical.Net on MSNUncommon ovarian tumors detected in a single patientA new case report was published in Oncoscience's Volume 12 on March 31, 2025, titled "Cystadenofibroma and contralateral collision lesions: A unique ovarian case report." ...
Jefferies analyst Kelly Shi initiated coverage of Verastem (VSTM) with a Buy rating and $15 price target The company has an FDA action date on ...
Spanish soccer club Leganes has joined the fight against testicular cancer by planning to wear attention-grabbing shorts for its upcoming game against Barcelona.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results